ReNeuron Group plc
RNUGF · OTC
9/30/2023 | 3/31/2023 | 9/30/2022 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $6 | $9 | $10 |
| Short-Term Investments | $0 | $1 | $1 | $5 |
| Receivables | $0 | $1 | $0 | $1 |
| Inventory | $0 | -$2 | $0 | -$2 |
| Other Curr. Assets | $0 | $3 | $2 | $3 |
| Total Curr. Assets | $6 | $9 | $13 | $16 |
| Property Plant & Equip (Net) | $0 | $1 | $1 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $1 | $1 | $1 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6 | $10 | $14 | $17 |
| Liabilities | – | – | – | – |
| Payables | $4 | $0 | $6 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$0 | -$6 |
| Other Curr. Liab. | $0 | $4 | $0 | $12 |
| Total Curr. Liab. | $4 | $4 | $6 | $7 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $1 |
| Total Liabilities | $4 | $5 | $7 | $7 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $1 | $1 | $1 |
| Retained Earnings | -$155 | -$152 | -$150 | -$147 |
| AOCI | $0 | $40 | $43 | $40 |
| Other Equity | $156 | $116 | $114 | $116 |
| Total Equity | $2 | $5 | $7 | $10 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $6 | $10 | $14 | $17 |
| Net Debt | -$5 | -$6 | -$9 | -$9 |